Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin

International Journal of Antimicrobial Agents

Volumn 37, Issue 6, 2011, Pages 547-549

  Harris, Patrick ^a   Engler, Cathy ^a   Norton, Robert ^a  

^a TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Carbapenem; Disk diffusion; Etest; Fluoroquinolone; Glycylcycline; Melioidosis

Indexed keywords

DORIPENEM; ERTAPENEM; MEROPENEM; MOXIFLOXACIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; COMPARATIVE STUDY; CONTROLLED STUDY; DISK DIFFUSION; DRUG STABILITY; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BETA-LACTAMS; BURKHOLDERIA PSEUDOMALLEI; CARBAPENEMS; HUMANS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; QUINOLINES;

EID: 79955478211     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.02.001     Document Type: Article

References (20)

1. B.J. Currie, D.A. Dance, and A.C. Cheng The global distribution of Burkholderia pseudomallei and melioidosis: an update Trans R Soc Trop Med Hyg 102 Suppl. 1 2008 S1 S4
2. N.J. White, and Melioidosis Lancet 361 2003 1715 1722
3. D. Limmathurotsakul, W. Chaowagul, N.P. Day, and S.J. Peacock Patterns of organ involvement in recurrent melioidosis Am J Trop Med Hyg 81 2009 335 337
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI; 2010.
5. A.C. Cheng Melioidosis: advances in diagnosis and treatment Curr Opin Infect Dis 23 2010 554 559
6. N.J. White, D.A. Dance, W. Chaowagul, Y. Wattanagoon, V. Wuthiekanun, and N. Pitakwatchara Halving of mortality of severe melioidosis by ceftazidime Lancet 2 1989 697 701 (Pubitemid 19243112)
7. M.D. Smith, V. Wuthiekanun, A.L. Walsh, and N.J. White In-vitro activity of carbapenem antibiotics against β-lactam susceptible and resistant strains of Burkholderia pseudomallei J Antimicrob Chemother 37 1996 611 615 (Pubitemid 26116974)
8. T.J. Inglis, F. Rodrigues, P. Rigby, R. Norton, and B.J. Currie Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods Antimicrob Agents Chemother 48 2004 2999 3005 (Pubitemid 38989167)
9. T.R. Fritsche, M.G. Stilwell, and R.N. Jones Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003) Clin Microbiol Infect 11 2005 974 984 (Pubitemid 41748931)
10. D.A. Dance, V. Wuthiekanun, W. Chaowagul, Y. Suputtamongkol, and N.J. White Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei J Antimicrob Chemother 28 1991 321 324
11. A.W. Jenney, G. Lum, D.A. Fisher, and B.J. Currie Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis Int J Antimicrob Agents 17 2001 109 113 (Pubitemid 32101565)
12. R. Karunakaran, and S.D. Puthucheary Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials Scand J Infect Dis 39 2007 858 861 (Pubitemid 47470774)
13. V. Thamlikitkul, and S. Trakulsomboon In vitro activity of doripenem against Burkholderia pseudomallei Antimicrob Agents Chemother 53 2009 3115 3117
14. K. Berthoin, C.S. Le Duff, J. Marchand-Brynaert, S. Carryn, and P.M. Tulkens Stability of meropenem and doripenem solutions for administration by continuous infusion J Antimicrob Chemother 65 2010 1073 1075
15. M.N. Samtani, R. Flamm, K. Kaniga, and P. Nandy Pharmacokinetic- pharmacodynamic-model-guided doripenem dosing in critically ill patients Antimicrob Agents Chemother 54 2010 2360 2364
16. K. Ikawa, N. Morikawa, S. Uehara, K. Monden, Y. Yamada, and N. Honda Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients Int J Antimicrob Agents 33 2009 276 279
17. British Society for Antimicrobial Chemotherapy. BSAC methods for antimicrobial susceptibility testing. Birmingham, UK: BSAC; 2010. http://www.bsac.org.uk/Resources/BSAC/Version-9.1-March-2010-final.pdf [accessed 20 November 2010].
18. P. Chetchotisakd, W. Chaowagul, P. Mootsikapun, D. Budhsarawong, and B. Thinkamrop Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline Am J Trop Med Hyg 64 2001 24 27 (Pubitemid 32550093)
19. W. Chaowagul, Y. Suputtamongkul, M.D. Smith, and N.J. White Oral fluoroquinolones for maintenance treatment of melioidosis Trans R Soc Trop Med Hyg 91 1997 599 601 (Pubitemid 27478659)
20. J.E. Frampton, and M.P. Curran Tigecycline Drugs 65 2005 2623 2635 [discussion 2636-7] (Pubitemid 43049957)